Table:
begin	end	state
1	28	signal peptide
29	40	non-cytoplasmic
41	64	transmembrane
65	81	cytoplasmic
82	103	transmembrane
104	147	non-cytoplasmic
148	169	transmembrane
170	196	cytoplasmic
197	218	transmembrane
219	223	non-cytoplasmic
224	250	transmembrane
251	261	cytoplasmic
262	283	transmembrane
284	312	non-cytoplasmic
313	330	transmembrane
331	336	cytoplasmic
337	354	transmembrane
355	359	non-cytoplasmic
360	382	transmembrane
383	422	cytoplasmic

Input:
>WP_200770547.1 NCBI__GCF_900141795.1:WP_200770547.1
MKLALHWQILLALALAVLMGWLTGTDATILGVHWIAIYDFIGTLFLNALKMVVVPLVMAA
IITGMASIARQGGFGRLGLKTLGYYLMTSAIAILIGITLVNLIQPGVSDNPPPQIAADTQ
LQQKLEGRDIGDIAEVFLRMIPTNIVEAAAETQMLGLIFFSLLFGYFMMKIQTPYRDTLY
NFWQGVFEVMMQITEWVMKFAPLGVFGLVAASVARTGFDQFANLALFFITVVLALGIHFF
VVMPLILRFIGGVRNPWKHYKVMLPAILTAFSTSSSASTLPVTIECVERGAGVPNRISGF
VLPLGATVNMDGTALYEAVAALFIAQLFGVHLDVTQQFMIIVIALLTSIGVAGIPSASLV
AISIILVSVGLPAEAIGLLLVVDRLLDMMRTTVNIFSDSVGAVVIARSEGEKDVLEGDGR
CG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server